Skip to main content
OpenTrials

Clinical trial condition

Complete Hematologic Remission (CHR)

Explore clinical trials studying Complete Hematologic Remission (CHR). Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Complete Hematologic Remission (CHR) trial results

Completed

Phase I Study of Adoptive Immunotherapy With Enriched and Expanded Autologous Natural Killer (NK) Cells for Patients With Ph+ Acute Lymphoblastic Leukemia (ALL)

NCT02185781

Conditions
Acute Lymphoblastic Leukemia, Complete Hematologic Remission (CHR), Hematologic Diseases, +15 more
Locations
  • ISS/AIFA Roma, Italy
  • Ospedale S. Eugenio Roma, Italy
  • Università Cattolica del Sacro Cuore - Policlinico A. Gemelli Roma, Italy
  • Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia Roma, Italy
View Trial Details

Related conditions